NASDAQ: SHFS

●
Cannabis-related
deposit services: We originate, onboard, verify, and service cannabis-related deposit business for and on behalf of our
financial institutions, primarily PCCU, and constitute obligations solely of those institutions; the Company is not a financial institution
and does not hold customer deposits on its consolidated balance sheet. Because most CRBs transact with high volumes of cash due to the limited availability of traditional banking
services, our platform benefits both CRBs and financial institutions by providing CRBs access to compliant banking and giving
financial institutions access to increased, compliantly monitored deposits.

●
Lending
services: We source, underwrite, service, and administer loans issued to cannabis businesses and related entities, many
of which are also clients of our partner financial institutions.

We
generate revenue through fee income, investment income, and loan program income earned by providing these compliance and lending services
to financial institutions serving the cannabis industry.

Financial
Services Platform

We
have developed and commercialized a proprietary financial services platform, known as the Safe Harbor Program (the “Program”),
which enables financial institutions to provide compliant banking services to CRBs. Our platform is currently deployed across 41 states
and territories and is designed to guide financial institution customers and CRBs through the full lifecycle of account onboarding, validation,
and ongoing compliance monitoring in a manner consistent with applicable banking regulations and regulatory guidance.

The
platform serves as an automated management tool that allows our employees to deliver continuity of service while enabling compliance
staff to efficiently monitor BSA and AML activities. It is intended to satisfy the compliance standards
required by state and federal banking regulators, and since inception, we have assisted in the processing of approximately $35.4 billion
in cannabis-related depository funds and successfully supported our financial institution clients through more than 25 state and federal
banking examinations.

It is important to note that the Company is not a financial institution and does not include loans or customer deposits,
which are associated with financial institutions, on its consolidated balance sheet. All deposit accounts are held by our financial institution
customers, and all funds transmitted to and from those accounts are handled directly by those institutions. Our role is to provide the
compliance infrastructure, technology, and CRB client relationships that enable our financial institution partners to serve the cannabis
industry.

7

We
also license the Program to financial institutions that wish to independently provide compliant cannabis banking services. Under these
licensing arrangements, we provide:

●Initial
customer due diligence (e.g., KYC);

●Program
management support;

●Regulatory
examination assistance;

●Customer
application management;

●Compliance
monitoring; and

●Regulatory
examination assistance.

We
believe our platform and processes have been implemented in a manner that is consistent with applicable laws and regulations. Our track
record in developing compliance processes that satisfy regulatory standards has established a strong reputation with relevant regulatory
authorities, which we believe positions us well to continue growing our existing service offerings and to expand into new ones.

CRB
Deposits

We
maintain relationships with PCCU and other financial institution partners in which CRB funds are deposited and monetary transactions
are processed. Our proprietary platform connects with the core banking systems of these institutions, enabling us to monitor deposit
accounts we have onboarded and to extract the data necessary to help ongoing compliance. All fund transmissions including wires, ACH
transactions, and other transfers are processed directly through our financial institution partners’ infrastructure. The Company
itself is not a financial institution and does not hold customer deposits.

How
We Generate Revenue from Deposit Maintained at Financial Institutions?

We
generate revenue from deposit maintained at financial institutions in three primary ways. First, we may assess an initial
onboarding fee when a CRB or ancillary service provider begins banking through one of our financial institution partners. This fee
reflects the time and complexity involved in completing the KYC and BSA due diligence that is required before an account can be
opened. Second, we earn monthly deposit and account activity fees that are based on business type, account size, and transaction
activity. Third, we earn investment income when our financial institution partners invest CRB deposits in low-risk, liquid assets.
The amount of investment income we earn is directly influenced by the level of deposits under their management and the prevailing
interest rate environment.

8

Our
Relationship with PCCU

PCCU
is our primary financial institution partner and the holder of the majority of CRB deposit accounts we service, and this relationship
is governed by the Second Amended CAA. Under the Second Amended CAA, we provide PCCU with the compliance infrastructure, technology, and
CRB client relationships needed to serve the cannabis industry, and in return we earn account servicing fees, investment income on CRB
deposits, and a share of loan program income on CRB loans originated through PCCU. We also pay PCCU a monthly asset hosting fee for
access to its regulated banking platform and infrastructure. The Second Amended CAA will expire on December 31, 2031, afterwards the
agreement will automatically renew for periods of two years unless we or PCCU provides a non-renewal notice twelve months prior to the
expiration of the then-current period.

Because
PCCU accounts for a significant portion of our revenue, the loss of or a material change to this relationship could have a material adverse
impact on our results of operations and financial condition. See Part 1, Item 1A., “Risk Factors––Risks Related to
the Second Amended CAA,” Part II, Item 7., “Management’s Discussion and Analysis of Financial Condition and Results
of Operations for the Years ended December 31, 2025 and 2024––Relationship with PCCU,” “Management’s Discussion
and Analysis of Financial Condition and Results of Operations for the Years ended December 31, 2025 and 2024––Related Party
Relationship with PCCU” and Note 10 to the Company’s consolidated financial statements in this Form 10-K for additional detail
on our relationship with PCCU and the terms of the Second Amended CAA.

Commercial
Lending Program

Commercial
lending is a key component of our business and an important source of revenue. Our lending program is designed to specifically address
the unique financing needs of CRBs, which often have limited access to traditional credit markets. We assist, service, and
administer loans on behalf of our financial institution partners, with the majority of lending currently funded through PCCU using CRB
deposit balances that we have onboarded and continue to manage.

Our
lending program is focused primarily on senior secured loans, with collateral including real estate, equipment, accounts receivable,
and other business assets. Unsecured lending opportunities are also considered on a selective basis. Our approach to credit is built
on three core principles: thorough investigations of both collateral and borrower creditworthiness; disciplined loan-to-value requirements;
and a deep knowledge of the cannabis industry, including the operational and business cycle dynamics unique to CRB borrowers.

Our
loan operations team is directly involved in each step of the lending process, including initial due diligence, underwriting, loan closing
and documentation, ongoing servicing, payment processing, borrower monitoring, risk rating, and workout and collections when necessary.
PCCU’s loan committee retains final approval authority over all credit decisions, and PCCU is the legal lender of record under
all loan agreements. We earn a share of the loan program income on loans originated through PCCU under the terms of the Second Amended
CAA. See “––CRB Deposits” above and Note 10 to the Company’s consolidated financial statements in this
Form 10-K for additional information.

Our
available lending capacity is directly tied to the size of our managed deposit base, as the amount we can arrange in loans through PCCU
is based on a regulatorily stipulated percentage of average CRB deposits. We are incentivized to deploy available lending capacity, as
loan program income on funded loans generally exceeds the investment income that would otherwise be earned on the same deposits. Growing
and retaining the CRB deposit base therefore remains central to our ability to expand the lending program.

In
2025, we executed lending program agreements with certain companies that provide us access to private capital sources, including
family offices and private equity funds. These agreements provide additional funding channels for CRB loans outside of our PCCU
relationship. These agreements are intended to diversify our lending capacity and reduce our dependence on a single funding source.
The Company did not have any revenue from these arrangements, we believe these agreements represent an
important avenue for future growth as we continue to build and deploy the lending program.

Our
Mission

Our
mission is to serve as the trusted financial partner to CRBs and the financial institutions that serve them by providing the compliance
infrastructure, lending access, and operational support to allow them to operate, grow, and succeed in a highly regulated industry. We
are committed to being the most reliable and knowledgeable financial services provider in the cannabis sector, and to expanding the range
of services we offer as the industry matures.

We
believe our competitive position is based on four strengths that are difficult to replicate: a decade of demonstrated experience
navigating the regulatory requirements and passing many audits of cannabis banking; deep cannabis domain expertise amongst our
employees and management, long-standing relationships with both CRBs and the financial institutions that serve them; and a
proprietary compliance platform that has processed approximately $35.4 billion in cannabis-related deposit activity across 41 states
and territories since 2015. These capabilities allow us to serve a broad range of cannabis industry participants, including
cultivators, processors, manufacturers, dispensaries, and multi-state operators, as well as the financial institutions that wish to
bank them.

9

Growth
Initiatives

We
are pursuing growth through four complementary growth initiatives:

●We
are focused on growing our core deposit and lending business organically by increasing the
number of CRB accounts we onboard and manage for our financial institutions, deepening relationships with existing and potentially
new financial institution partners, and by deploying more of our available lending capacity
through PCCU and our expanding network of private capital partners.

●In
December 2025, we acquired substantially all of the assets of LBMW LLC, a Delaware limited
liability company doing business as 420 IT Solutions (“420 IT Solutions”), a
company that provided on-site due diligence review services to cannabis-friendly financial
institutions. This acquisition added capabilities that are complementary to our existing
compliance platform and expanded the suite of services we can offer to financial institution
customers seeking to enter or grow their cannabis banking programs.

●We
are investing in the development of a managed services business that will offer outsourced
consulting and operational support directly to CRBs and financial institutions. These are
expected to include outsourced finance, accounting, treasury, information technology, and
human resources services, as many CRBs lack the internal infrastructure to operate in these
areas efficiently. We generated initial revenue from this business line in 2025, though it
was not material. We are actively investing to build this capability and grow it into a meaningful
revenue contributor over time.

●We
are growing through strategic partnerships with third parties who can expand our reach, capabilities,
and capital base. In 2025, we executed lending program agreements that allow us to access
private capital sources, including family offices and private equity funds, to provide additional
funding capacity for CRB loans outside of our PCCU relationship. These partnerships are
intended to reduce our funding concentration risk and increase the volume of loans we are
able to originate and service.

We
are also pursuing partnerships with other CRB-focused service providers whose offerings are complementary to ours, with the goal of creating
a more integrated set of solutions for cannabis businesses and the financial institutions that serve them. While revenue from these partnership
channels was not material in 2025, we believe they represent an important foundation for future growth.

We
believe that the combination of our established compliance and banking infrastructure, our expanded on-site review capabilities following
the acquisition of the assets of 420 IT Solutions, our emerging managed services business, and our growing network of capital and strategic
partnerships positions us to serve cannabis businesses and financial institutions more comprehensively than any other provider in our
market.

Industry
Overview

The
U.S. Cannabis Market

The
United States cannabis industry has grown into one of the largest and most economically significant emerging sectors in the American
economy. In 2025, total U.S. state-licensed cannabis market revenues were estimated at approximately $30.4 billion, with forecasts projecting
the market to reach approximately $31.5 billion in 2025 and potentially exceed $76 billion by 2030, reflecting a compound annual growth
rate of approximately 19%. The industry supports an estimated 425,000 full-time jobs nationwide and generated more than $4.4 billion
in state and local tax revenues in 2025. In addition, the intoxicating hemp market had an estimated value of $21.8 billion in 2025.

The
regulatory landscape has continued to evolve at the state level. As of the date hereof, 40 states, three territories, and the District
of Columbia permit the medical use of cannabis, and 24 states, two territories, and the District of Columbia have enacted laws permitting
adult-use recreational cannabis. Despite this broad state-level acceptance, cannabis remains classified as a Schedule I controlled substance
under the Controlled Substances Act (the “CSA”), creating a persistent gap between state and federal law that fundamentally
shapes how cannabis businesses operate, including their ability to access banking and financial services, obtain standard business financing,
and manage their tax obligations.

Federal
Regulatory Developments - Rescheduling to Schedule III

The
federal regulatory environment for cannabis has undergone significant and evolving changes recently, and the Company believes these developments
are material to an understanding of the industry in which it operates.

In
August 2023, the U.S. Department of Health and Human Services (“HHS”) recommended that the Drug Enforcement Administration
(“DEA”) reschedule cannabis from Schedule I to Schedule III of the CSA, concluding that cannabis has a currently accepted
medical use and a lower potential for abuse than Schedule I or Schedule II substances. In May 2024, the U.S. Department of Justice issued
a Notice of Proposed Rulemaking proposing to move cannabis from Schedule I to Schedule III. The proposed rule generated nearly 43,000
public comments. While a formal DEA administrative hearing was initially scheduled for January 2025, that hearing was stayed by the presiding
administrative law judge pending resolution of procedural appeals, and the rescheduling process effectively stalled for much of 2025.

On
December 18, 2025, President Donald Trump signed an Executive Order titled Increasing Medical Marijuana and Cannabidiol Research,
directing the Attorney General of the United States to “take all necessary steps to complete the rulemaking process related to
rescheduling marijuana to Schedule III of the CSA in the most expeditious manner in accordance with Federal law.” This Executive
Order did not itself reschedule cannabis, as formal rescheduling requires completing the full rulemaking process, which includes DEA
issuing a final rule, however we believe it represents the most significant federal cannabis policy directive in more than 50 years and
signals a clear intent within the executive branch of the federal government to bring the rescheduling process to conclusion.

Legal
challenges to the rescheduling process are anticipated. Organizations opposing rescheduling may argue that the proposed rule is procedurally
flawed or scientifically unsupported, and litigation under the Administrative Procedure Act is possible after a final rule is published.
The ultimate timing of any final rescheduling rule therefore remains uncertain, and investors should not rely on any specific timeline
for completion of the rescheduling process.

We
believe the most immediate and financially material consequence of rescheduling would be the elimination of Section 280E of the Internal
Revenue Code (“Section 280E”). Under the current law, cannabis businesses classified as drug traffickers under federal law
because of the cannabis’ current Schedule I status are prohibited from deducting ordinary and necessary business expenses, including
payroll, rent, and marketing costs. This results in effective federal tax rates for cannabis operators that are materially higher than
those faced by businesses in other industries. Rescheduling to Schedule III could eliminate the Section 280E penalty, thereby improving
cash flows and profitability for state-legal cannabis operators across the country.

10

Rescheduling
could also encourage greater participation by academic institutions and pharmaceutical companies in researching the medicinal properties
of cannabis, as we believe such institutions and companies have historically avoided using Schedule I substances in their research.

The
Company does not believe that rescheduling, on its own, would eliminate the market for its services. In fact, the Company believes that
rescheduling could improve the financial stability of its CRB clients, which would as a result help support higher average account balances.
In addition, rescheduling could attract additional financial institutions to join the cannabis banking market, and the Company could
partner with some or all of these new entrants.

Banking
Access

Despite
the growth of state-legal cannabis markets, the vast majority of cannabis-related businesses continue to face constraints in accessing
basic banking and financial services. Because cannabis remains a Schedule I controlled substance under federal law, federally regulated
financial institutions including banks, credit unions, and payment processors face legal and regulatory risk when providing
services to CRBs. Financial institutions that serve CRBs are required to file Suspicious Activity Reports (“SARs”) for cannabis-related
transactions under the BSA and related Financial Crimes Enforcement Network (“FinCEN”) guidance, which creates a compliance
burden that many financial institutions appear unwilling to assume. As a result, the majority of CRBs continue to operate primarily in
cash and in turn this method of operation can create public safety risks, operational inefficiencies, and barriers to tax
collection and regulatory oversight.

A
bipartisan letter signed by 32 state attorneys general in July 2025 urged Congress to advance the SAFER Banking Act, which is designed
to protect federally regulated financial institutions from penalties when they provide services to state-sanctioned cannabis businesses.
The SAFER Banking Act has passed the U.S. House of Representatives in prior legislative sessions but has repeatedly failed to advance
in the Senate. The bill’s near-term prospects in the current Congress remain uncertain given current legislative dynamics and policy
priorities. The Company exists, in part, because of this structural gap in banking access and the need for compliance-driven platforms
that enable financial institutions to serve CRBs in a manner that is consistent with applicable federal banking regulations and Fin CEN
guidance.

Market
Headwinds and Industry Pressures

The
cannabis industry experienced meaningful financial and operational headwinds during 2024 and 2025. Wholesale cannabis prices declined
in some state markets due to oversupply and increasing competition, constraining operator revenues and reducing average deposit balances
across the industry. Cannabis operators collectively carry an estimated $2.5 billion in debt, only approximately 27% of cannabis companies
were profitable in 2024, compared to 42% of such companies in 2022. In addition, several large multi-state operators are facing significant
debt maturities. These pressures have been reflected in lower average account balances and reduced transaction activity across the Company’s
portfolio during 2025.

At
the same time, the Company believes there are meaningful catalysts for industry recovery. A potential rescheduling of cannabis could
materially improve operator cash flows and profitability. See “Federal Regulatory Developments-Rescheduling
to Schedule III.” In addition, broader improvements to the United States’ economy and the growth rate of consumer discretionary
spending could support higher cannabis sales volumes. The expansion of state-level markets could increase the number of CRBs as well.

The
Company believes that its platform, its established relationships with financial institution customers, and its proprietary compliance
infrastructure position it to benefit from an industry recovery as these factors develop.

Regulatory
Framework for Cannabis Banking

Under
current federal guidance, financial institutions that serve CRBs are required to operate under the framework established in FinCEN’s
2014 guidance memorandum, which outlined our expectations for BSA compliance, ongoing customer due diligence requirements, and SAR filing
obligations specific to cannabis banking. The guidance has never been superseded by statute, and financial institutions operating in
the cannabis banking space continue to face regulatory examination risk, possible reputational harm in the event of a violation, and
the ongoing administrative burden of SAR filings. The Company’s platform and compliance program are designed to address these requirements
directly, thereby enabling its financial institution partners to serve CRBs with confidence in their regulatory compliance.

11

The
Company has assisted in the processing of approximately $35.4 billion in cannabis-related depository funds since 2015 and has successfully
navigated more than 25 state and federal banking examinations through its financial institution relationships. The Company currently
operates its platform across 41 states and territories, serving a diversified base of CRB clients and financial institution customers.

Business
Strategy

SHF’s
mission is to be the leading compliance-driven financial services platform for the U.S. cannabis industry, enabling partner financial
institutions to serve CRBs reliably, safely, and in full conformity with applicable federal and state regulatory requirements. Our strategy
is based on five priorities: stabilizing and organically growing our core platform business; deepening lending-related revenue through
our relationship with PCCU and other capital sources; building complementary service lines; maintaining and expanding financial institution
partnerships; and positioning the Company to benefit from anticipated favorable changes in the federal cannabis banking regulatory environment.

Loans
are extended to cannabis related businesses, including both licensed cannabis operators and ancillary service providers to the
cannabis industry. The cannabis industry continues to grow and expand at a rapid pace due in part to the on-going opening of
additional legalized cannabis markets at the state level. Due to the federally status of cannabis, most cannabis-related businesses
have experienced years of inability to access capital at reasonable rates, and these circumstances can force them to purchase
properties and equipment and fund their businesses from personal investment or reinvestment of cash from operations, which could
potentially limit their own growth. This creates a robust opportunity for us to lend to established entities with real estate assets
free of debt. Businesses are taking the opportunity to leverage such assets to expand and grow their operations while we build a
senior secured portfolio ostensibly collateralized with a real estate or other hard asset such as equipment.

Furthermore,
the industry has typically been subject to “hard money” lending with annual rates available between 18-36%. This is yet another
opportunity for us to offer refinancing of real estate and equipment loans at more favorable interest rates. Given that the depository
relationship is necessary as part of the compliance process, we benefit from servicing, monitoring, and validating compliance of depository
relationships, earning fees on deposits. This results in a lower cost of capital when accounting for the fact that we earn interest income on both
the depository and lending relationships.

Stabilize
and Organically Grow the Core Deposit and Compliance Platform

Our
primary business is providing compliance infrastructure, technology platforms, and ongoing monitoring services that allow partner
financial institutions to provide banking services to CRBs. Since 2015, we have assisted in the processing of approximately $35.4
billion in cannabis-related depository funds across a platform footprint of 41 states and territories, and through our financial
institution relationships, we have successfully navigated more than 25 state and federal banking examinations. These milestones
reflect the depth and durability of our compliance expertise and the strength of our established relationships with both CRBs and
financial institutions.

Our
near-term organic growth strategy focus is on increasing the number of CRB accounts we onboard and manage, deepening relationships with
existing financial institution partners, and selectively expanding to new financial institution partners to the extent market conditions
and our operational capacity can support it.

12

Another
key component of our organic growth strategy is early entry into emerging cannabis markets. We define “emerging markets”
as American states with cannabis programs that have launched or been materially expanded within the past five years. Our emerging market
portfolio spans three distinct opportunity categories:

●New
Markets Coming Online: In states that have recently launched or are actively implementing
cannabis licensing programs, such as Delaware, Minnesota, Kentucky, Alabama, and Mississippi,
we are working to establish banking relationships as operators prepare for launch, with account
activity evolving as businesses progress through their respective licensing and operational
phases.

●Licensing
Expansion in Established Adult-Use States: States expanding their licensing frameworks,
such as New York, New Jersey, Maryland, Connecticut, Missouri, and Ohio, increase the demand
for compliant banking services as new operators are allowed into these markets.

●Operator
Footprint Expansion: States such as Pennsylvania, Illinois, Virginia, and Florida, where
existing operators are scaling their operations, require more sophisticated banking and financial
services.

By
entering these markets early, often before licensing programs are fully developed, the Company aims to position itself as the
partner of choice for licensed operators navigating complex and evolving regulatory environments. In emerging markets, deposit
levels naturally fluctuate as operators progress through business cycles, from deploying startup capital during launch phases to
building working capital reserves as operations mature. See “Recent Developments Emerging Markets” for additional information.

Deepen
Lending Revenue Through the Second Amended CAA and Expanding Capital Partnerships

Under
the Second Amended CAA, we receive up to 65% of loan program income generated by PCCU’s CRB loan portfolio, an increase from
the approximately 35% share in effect from January 1, 2025 until September 30 2025, under the Amended and Restated Commercial Alliance Agreement dated
December 30, 2024 by and between the Company and PCCU (the “First Amended CAA”). In exchange, we are obligated to
indemnify PCCU for up to 65% of net losses of a default on any loan covered by the Second Amended CAA. As of December 31, 2025, the
CRB loan portfolio totaled approximately $52.1 million across 25 loans, with zero historical losses since the program’s
inception in 2023. Our strategy is to grow the loan portfolio responsibly by continuing to originate quality CRB loans through PCCU,
maintain rigorous credit underwriting standards, and build the cash reserves and capital access necessary to support our
indemnification obligations.

In
2025, we executed lending program agreements with certain companies that provide us access to private capital sources, including family
offices and private equity funds. These agreements provide additional funding channels for CRB loans outside of our PCCU relationship.
These agreements are intended to diversify our lending capacity and reduce our dependence on a single funding source. The Company did not have any revenue from these arrangements, we believe these agreements represent an important
avenue for future growth as we continue to build and deploy the lending program.

The
September 2025 Recapitalization (as defined below) eliminated approximately $18 million in debt and raised gross proceeds of $6.7
million in new capital, and also resulted in the establishment of the $150 million Equity Line of Credit (“ELOC”) with
CREO Investments LLC (“CREO”) that can potentially be expanded to $500 million, thereby meaningfully improving our
ability to support our lending commitments and portfolio growth. During the fourth quarter of 2025, the Company issued 1,326,603
shares of Class A Common Stock (“Common Stock”) and received proceeds of approximately $1.8 million.

Build
Complementary Service Lines

In
December 2025, we acquired substantially all of the assets of 420 IT Solutions, a company that provided on-site due diligence review
services to cannabis-friendly financial institutions. This acquisition added capabilities that are complementary to our existing compliance
platform and expanded the suite of services we can offer to financial institution customers seeking to enter or grow their cannabis banking
programs. On-site reviews are a key component of BSA/AML compliance for cannabis-banking financial institutions, and bringing this capability
in-house strengthens both our service offerings and our compliance infrastructure.

13

In
addition, we are investing in the development of a managed services business that will offer outsourced consulting and operational support
directly to CRBs and financial institutions. These are expected to include outsourced finance, accounting, treasury, information technology,
and human resources services, as many CRBs lack the internal infrastructure to operate in these areas efficiently. We generated initial
revenue from this business line in 2025, though it was not material. We are actively investing to build this capability and grow it into
a meaningful revenue contributor over time.

Maintain
and Expand Financial Institution Partnerships

Our
business model depends on maintaining strong, trust-based relationships with our financial institution partners. PCCU remains our most
significant financial institution customer. We continue to partner with other financial institutions that wish to compliantly provide
banking services to CRBs, including with respect to KYC onboarding, ongoing compliance monitoring, program management support, and regulatory
examination assistance.

We
are also pursuing partnerships with other CRB-focused service providers whose offerings are complementary to ours, with the goal of creating
a more integrated set of solutions for cannabis businesses and the financial institutions that serve them. While revenue from these broader
partnership channels was not material in 2025, we believe they represent an important foundation for future growth.

Position
for Regulatory Tailwinds

We
believe the Company is well-positioned to capitalize on any cannabis-related rescheduling developments. As discussed above, we believe
that a rescheduling of cannabis from Schedule I to Schedule III would decrease tax burdens for cannabis operators and improve the financial
stability of CRBs.

The
potential impact of such reforms on our current and prospective financial institution partners could be significant. According to FinCen
approximately 998 depository institutions, 816 banks and 182 credit unions, were actively filing marijuana-related SARs, which is the
primary indicator that an institution is serving CRBs, as of December 2024. This represents less than 11% of the approximately 9,140
Federal Deposit Insurance Corporation- and National Credit Union Administration-insured depository institutions operating in the United
States as of December 31, 2024. In addition, industry analysts estimate that less than 200 financial institutions nationwide have a dedicated,
actively marketed cannabis banking program.

We
believe the primary reason the vast majority of U.S. financial institutions have not entered the cannabis banking market is regulatory
risk and the compliance burden. Under current federal law and the 2014 FinCEN guidance, every institution serving a CRB must file initial
and continuing SARs on a quarterly basis, establish and maintain enhanced BSA/AML compliance programs, and accept the reputational and
examination risk that accompanies providing banking services in connection with a federally controlled substance. This compliance burden
represents the market barrier that the Company’s platform is specifically designed to address. We believe that passage of the SAFER
Banking Act or related federal cannabis banking legislation, or regulatory relief related to the rescheduling of cannabis to Schedule
III, would meaningfully lower that barrier and expand the scope of financial institutions willing to enter the cannabis banking market.
An increase in the number of financial institutions seeking to serve CRBs would represent a larger market for our compliance services.
Regulatory relief would, in our view, be more likely to accelerate the adoption of cannabis banking programs by financial institutions
than to make our compliance infrastructure obsolete, given that state-level regulatory requirements, ongoing due diligence obligations,
and BSA program management would remain necessary regardless of federal scheduling changes.

Operational
Efficiency and Financial Discipline

Following
the September 2025 Recapitalization and the restructuring of the Commercial Alliance Agreement (“CAA”) with PCCU in
February 2026, we are focused on operating with greater financial discipline. With no material debt outstanding as of December 31,
2025, and improved liquidity from the recapitalization and the ELOC, our near-term priorities include reducing operating costs,
improving cash generation, and maintaining the cash reserves required to support our lending indemnification obligations under the
Second Amended CAA.

14

We
believe that the combination of our established compliance and banking infrastructure, our expanded on-site review capabilities through
the 420 IT Solutions asset acquisition, our emerging managed services offerings, and our growing network of capital and strategic partnerships
positions us to serve cannabis businesses and financial institutions more comprehensively than any other provider in our market

Sales
and Marketing

Our
sales and marketing efforts are focused on three audiences: financial institutions seeking to enter or expand their cannabis banking
programs, CRBs seeking access to compliant banking and financial services, and the broader regulatory and legislative community whose
decisions shape our operating environment.

We
generate new financial institution relationships primarily through direct outreach, referrals from existing partners, and participation
in industry conferences and events. Our leadership team actively engages in speaking opportunities and thought leadership forums that
position the Company as a recognized authority in cannabis banking compliance. We also maintain relationships with state regulators,
legislators, and attorneys general to support awareness of compliant cannabis banking frameworks and to contribute to policy discussions
as they evolve.

CRB
customer acquisition is largely driven by referrals from our financial institution partners and from existing CRB customers, reflecting
the trust-based nature of our platform. We also support customer acquisition and retention through targeted outreach, referral programs,
and success fee arrangements that align our growth incentives with those of our partners.

In
2025, we completed a comprehensive rebrand of the Company and its digital presence, repositioning the Company around a unified value
proposition that we are the Company where cannabis businesses can come to bank, borrow, operate, and grow. The rebrand included a full
redesign of our website and client-facing materials to reflect the expanded scope of our platform beyond compliance and deposit services.

Also
in 2025, we formalized and professionalized our Safe Harbor Partner Program by hiring a Senior Vice President of Strategic Partnerships
and enrolling more than a dozen third-party partners. These partners refer CRB clients to our platform in exchange for referral fees,
while referred CRB clients receive preferential pricing on our services. Although the program was not a material revenue contributor
in 2025, it represents an important investment in our distribution infrastructure and is expected to support client acquisition growth
in 2026 and beyond.

The
December 2025 acquisition of substantially all of the assets of 420 IT Solutions also meaningfully expanded our field presence. Our team
now can conduct on-site reviews at financial institutions and CRB locations across the country, and our established presence in key cannabis
markets provides the Company with additional capacity to attend industry events, build relationships with prospective clients, and support
business development activity in growth markets where in-person engagement is an important part of building trust.

To
support broader brand awareness and investor communications, we work with outside public relations and investor relations advisors and
maintain an ongoing program of digital marketing, search engine optimization, and direct outreach to current and prospective clients.

Competition

The
market for cannabis-related banking and financial compliance services is competitive and evolving. We face competition from two primary
sources: (1) software-as-a-service (“SaaS”) compliance technology providers that enable financial institutions to build and
operate their own cannabis banking programs and (2) integrated financial technology (“fintech”) company platforms that combine
regulatory compliance solutions with broader financial services offerings. We believe we compete on the basis of our regulatory reputation,
compliance track record, depth of cannabis industry expertise, breadth of financial services, quality of client relationships, and the
overall value of our platform.

15

SaaS
Compliance Technology Providers

A
number of companies offer software platforms designed to provide financial institutions with the compliance infrastructure and monitoring
tools necessary to provide banking services to CRBs without engaging a specialized third-party compliance provider. These platforms provide
KYC tools, BSA monitoring, SAR preparation, and related compliance workflows that financial institutions can operate internally. By lowering
the cost and amount of expertise required for a financial institution to build its own cannabis banking program, these SaaS providers
reduce barriers to entry for banks and credit unions that have not historically participated in the cannabis banking market. We believe
our competitive advantages over these providers include our more than 10-year operational track record in cannabis banking, our established
relationships with state and federal banking regulators, our zero-lending-failure history, and the depth of our full-service platform,
which extends well beyond software tooling to include client onboarding, ongoing relationship management, lending support, and regulatory
examination assistance.

Integrated
Fintech Platforms Offering Regulatory Compliance Solutions

A
second source of competition comes from fintech companies that bundle regulatory compliance capabilities with complementary financial
services, such as payment, supply chain management, or lending, into a vertically integrated suite of services. These platforms seek
to serve CRBs through this suite of services, thereby increasing customer switching costs and reducing the need for a standalone compliance
and banking infrastructure provider. Competitors in this category include financial institutions that have developed proprietary compliance
and banking capabilities specifically tailored to the cannabis industry, as well as specialty lenders that combine capital deployment
with advisory services.

Competitive
Dynamics and Risks

We
expect competition to increase as the cannabis industry matures, as additional states legalize cannabis for medical and/or adult use,
and as federal regulatory developments, including the potential rescheduling of cannabis under the CSA, reduce barriers that have historically
limited larger financial institutions’ participation in the market. If cannabis is rescheduled to Schedule III, we believe that
a broader set of well-capitalized banks, credit unions, and fintech companies would likely seek to enter into or expand their presence
in the cannabis banking market, potentially reducing our competitive differentiation and increasing pricing pressure on the fees we charge.

Despite
these risks, we believe our primary competitive strengths include the following:

●Our
leadership team’s rare combination of areas of expertise. We believe we are uniquely
positioned as the only fintech cannabis financial solution whose executive leadership team,
including our Chief Executive Officer, brings together direct, hands-on experience in cannabis
operations, financial services, and banking. This integrated expertise allows us to serve
cannabis-related businesses with a depth of understanding that we believe no competitor can
replicate.

●Our
established regulatory reputation and proven track record. Since our founding in 2015,
we have successfully navigated more than 25 state and federal banking examinations, a record
we believe is unmatched in our industry and reflects the rigor and integrity of our compliance
infrastructure.

●Our
proprietary compliance management platform. Our technology platform, operating across
41 states and territories, has facilitated the processing of approximately $35.4 billion in
cannabis-related depository funds since 2015. The platform enables financial institution
partners to provide BSA and FinCEN-compliant banking services to CRBs, including KYC onboarding,
ongoing transaction monitoring, and regulatory exam support.

●Our
comprehensive suite of financial services for CRBs. Through our financial institution
customers and strategic partners, we offer CRBs access to business checking and savings accounts,
cash management, commercial lending, ACH and wire payment services, remote deposit, and ancillary
compliance consulting, addressing the full spectrum of financial needs that CRBs face in
an underserved market.

We
cannot assure you, however, that we will be able to compete successfully against current or future competitors, and increased competition
could materially and adversely affect our business, financial condition, and results of operations. For additional information, see Part
I, Item 1A., “Risk Factors.”

16

Intellectual
Property

The acquisition of substantially all of the assets
of 420 IT Solutions included the transfer of, among other things, the registered trademark “420 IT Solutions”, domain name
registrations, and other intellectual property, including 420 IT Solution’s whitepaper of banking compliance services and site inspection
templates.

Except as described above, we do not have any registered intellectual property, and therefore we currently rely
on confidentiality, and non-disclosure agreements with our employees and others to protect our proprietary rights. Despite these
efforts to protect ourselves from infringement or misappropriation of our intellectual property rights, unauthorized parties may
attempt to copy or otherwise obtain and use our intellectual property in violation of our rights. In the event of a successful claim
of infringement against us, or our failure or inability to develop non-infringing intellectual property or license the infringed or
similar intellectual property on a timely basis, our business could be harmed.

Seasonality

Most
loan production is generally subject to seasonality, with the lowest volume typically being in the first quarter of each year. This does
not necessarily apply to us as we serve the cannabis industry with demands for access to capital at reasonable rates throughout the year.
We expect, based upon our pipeline of demand, a methodical and consistent growth in the lending portfolio.

Investments

The
Company’s investment activities are limited in scope and are guided by four core principles: investment quality, liquidity, interest-rate
risk management, and return on investment. Given the nature of our business and our obligations under the Second Amended CAA, maintaining
adequate liquidity is our primary investment objective.

Most
of the Company’s liquid assets are held in cash and cash equivalents, including interest-bearing money market accounts. The Company
does not maintain a significant portfolio of marketable securities.

During
2025, the Company acquired 1.5 million preferred securities of Aditxt, Inc. (“ADTX”) for $1.5 million, which is accounted
for at cost less impairment under Accounting Standards Codification (“ASC”) 321, as the preferred shares are not actively
traded and do not have a readily determinable fair value. During the year ended December 31, 2025,
the Company received redemption proceeds
of approximately $0.05 million for 43 shares
of ADTX. As of December 31, 2025, the Company holds 1,457 preferred securities of ADTX having carrying value
of $1.45 million. This investment is classified as long-term and will be periodically assessed for impairment or observable price
changes.

The
Company does not engage in speculative investment activity and does not hold derivative financial instruments for investment purposes.

Regulations
and Legislation

Cannabis
remains a Schedule I controlled substance under the CSA, making it illegal under federal law despite being legal for medical and/or adult
recreational use in a majority of U.S. states. This conflict between federal and state law is the central regulatory reality shaping
our business.

The
Federal-State Conflict and Its Impact on Banking

Because
cannabis remains federally illegal, most financial institutions are unwilling to provide banking services to CRBs. The risks deterring
participation include potential federal prosecution, civil asset forfeiture exposure, reputational risk, and significant BSA compliance
obligations. FinCEN issued guidance in February 2014 establishing a framework for how financial institutions may serve the cannabis industry
while meeting their BSA and AML obligations. While this guidance created a path forward, it also imposed substantial compliance burdens,
including detailed customer due diligence, transaction monitoring, and SAR filing obligations, that most financial institutions are unwilling
or unable to resource adequately.

We
believe the absence of a federal “safe harbor” for financial institutions and their officers and directors who service CRBs
remains the single most significant structural barrier to entry in this market, and this was the primary reason the Company was founded
and continues to operate.

17

Pending
and Recent Federal Legislation

Congress
has made several attempts to address the banking access problem. The SAFE Banking Act of 2021 (the “SAFE Banking Act”) passed
the U.S. House of Representatives in April 2021, and an updated version, the SAFER Banking Act, passed the Senate Banking Committee in
September 2023. As of the date of this filing, neither bill has been enacted into law. We continue to monitor legislative developments
closely.

Separately,
HHS recommended in 2023 that cannabis be rescheduled from Schedule I to Schedule III under the CSA. This recommendation was forwarded
to the DEA and remains pending. If rescheduling occurs, it could meaningfully impact cannabis businesses, including by modifying the
application of Section 280E, which currently prohibits ordinary business deductions for companies trafficking in Schedule I substances.
Greater after-tax cash flow for CRBs could increase deposit activity and borrowing capacity both of which would benefit the Company.

We
do not believe passage of the SAFE Banking Act or the SAFER Banking Act alone would significantly reduce the barriers to entry that define
our competitive advantage. The high cash-intensity of the cannabis business, its illicit history, and the ongoing presence of an illicit
market mean that BSA compliance obligations will remain demanding regardless of whether a safe harbor is enacted. We expect many potential
competitors will continue to avoid the sector.

Our
Compliance Framework

The
Company operates in a compliance-first manner aligned with the 2014 FinCEN Guidance and BSA requirements. Although we are not a chartered
financial institution, our agreements with financial institution partners require that we provide services consistent with applicable
regulatory standards. Our compliance program includes comprehensive written policies and procedures, ongoing and annual employee training,
quarterly and annual third-party compliance audits, and continuous assessments by management. These policies are formally reviewed at
least annually. The Company has successfully navigated more than 25 state and federal regulatory examinations with no adverse findings
attributable to our program.

Competitive
Barriers to Entry

The
regulatory environment has created both a barrier and an opportunity. While some fintech companies have attempted to enter this space
because these companies benefit from less restrictive regulatory requirements than chartered institutions, sustainable cannabis fintech
models require deep regulatory expertise, robust BSA programs, and reliable financial institution partnerships. We believe competition
remains limited for these reasons and that our established platform, proprietary technology, and compliance track record provide a durable
competitive advantage.

We
expect most large financial institutions to remain on the sidelines until federal legalization occurs, and even then, the cannabis sector
will require specialized compliance expertise that takes years to build. We also anticipate that regulatory requirements applicable to
fintechs will increase over time, further reinforcing the value of our established, compliance-tested program.

Concentrations

The
Company’s business is currently concentrated in two significant ways:

●Financial
Institution Partner Concentration.

Substantially
all of the Company’s revenue is derived from services provided to PCCU under Second Amended CAA. For the years ended December
31, 2025, and December 31, 2024, revenue generated under then-in-effect version of the CAA approximated 86.7% and 83.5% of the
Company’s total revenue, respectively. PCCU is also a significant related party. In addition, the Company receives revenue
from merchant services, which is a shared fee for the use of automated teller machines. Merchant service revenue for the years ended
December 31, 2025 and December 31, 2024, was approximately 9.7% and 8.6%, respectively. As of the date of this filing, PCCU holds
approximately 25% of the Company’s Common Stock. PCCU also holds approximately 43% of Series B Convertible Preferred Stock
(“Series B Preferred Stock”) and Common Stock purchase warrants (as amended and restated, each, a “Series B
Warrant”) combined, and is the largest holder of those securities. In the aggregate, PCCU’s holdings represent
substantial actual and potential ownership of the Company on a fully diluted basis. PCCU also holds substantially all of the cash
deposits of CRBs onboarded through the Company’s platform. The loss of, or a material adverse change to, the Company’s
relationship with PCCU would have a material adverse impact on the Company’s results of operations and financial condition.
The Company is actively working to expand its financial institution partner base to reduce this revenue concentration over time. The
Company has other sources of revenue, such as merchant services. During the year ended December 31, 2025, one financial institution
terminated its relationship with the Company.

18

●CRB
Deposit Concentration.

The
Company does not directly hold CRB deposit accounts. All deposit accounts are maintained at PCCU or other financial institutions,
and all fund transmissions are handled directly by those institutions. The Company’s fee income from onboarded deposits is well-diversified
at the individual CRB level. No one CRB account for the year ended December 31, 2025 represented more than 10% of total fee income from onboarded
deposits. The Company monitors account retention as a key indicator of its ability to efficiently
and compliantly onboard, validate, and monitor CRB accounts.

Loans
Receivables

The
Company does not originate or hold loans on its own balance sheet in the ordinary course of business. Loans to CRBs are originated and
funded by PCCU pursuant to the Second Amended CAA. The Company’s role is to identify, underwrite loans on PCCU’s
behalf, earning a share of loan program income. See “Overview–Our Relationship with PCCU” above.

During
the year ended December 31, 2025, the Company’s sole loan receivable, which had a carrying value of approximately $0.4 million
as of December 31, 2024, was sold, generating proceeds of approximately $0.4 million. As a result, the Company had no loans on its consolidated
balance sheet as of December 31, 2025.

For
further discussion of the loan program income sharing arrangement and the Company’s obligations under the Second Amended CAA,
see Note 9 to the Company’s consolidated financial statements in this Form 10-K.

Employees

As
of December 31, 2025, we had 39 full-time employees and one part-time employee. None of our employees are represented by a labor union
or covered by a collective bargaining agreement. Approximately 70% of our workforce is based in Colorado, with approximately 8% in Arkansas,
and the remainder distributed across six additional states. The Company utilizes a remote-capable workforce model that supports client
relationship management across the 41 states and territories in which we operate.

Human
Capital Management

Our
human capital strategy reflects the specialized nature of our business. Serving the cannabis industry at the intersection of financial
services and regulatory compliance requires employees with expertise that is difficult to recruit and takes significant time to develop.
Cannabis industry knowledge cannot be easily trained, as, although compliance and financial services skills can be taught, deep operational
understanding of the cannabis sector must be cultivated over time. Retaining experienced employees is therefore a direct operational
priority.

Our
human capital management focuses on the following areas:

●Talent
Acquisition and Retention. We recruit for specialized roles spanning cannabis
compliance, banking operations, relationship management, and information technology. Our
talent acquisition efforts are concentrated in sales, business development, and client-facing
roles that directly drive revenue. We offer competitive base compensation, performance-based
incentive programs, and equity participation through the Plan, which is intended to align
employee interests with long-term shareholder value creation.

●Performance
Management. The Company is transitioning to a performance-based compensation framework
that ties cash bonuses and equity grants to defined, measurable outcomes including revenue
growth, client acquisition, and operational efficiency. Performance evaluations are conducted
quarterly and annually and serve as the basis for compensation decisions and career development
planning.

19

●Learning
and Development. All employees receive ongoing compliance training aligned with BSA/AML
requirements and the 2014 FinCEN guidance. New employees complete industry-specific onboarding
covering cannabis banking compliance and the Company’s Code of Business Conduct and
Ethics, which is available on our website at www.shfinancial.org. We supplement internal
training with cannabis industry conferences and continuing education programs.

●Technology
and Productivity. We are actively investing in artificial intelligence-enabled compliance
management and customer relationship management tools designed to automate routine tasks
and increase individual employee output. This allows our team to focus on higher-value client-facing
activities as we grow, without a proportional increase in headcount.

●Compensation
and Benefits. We offer a competitive total rewards package including comprehensive
medical, dental, and vision coverage, with the Company contributing to employee premiums
on a tenure-based scale and funding a portion of employee Health Savings Accounts monthly.
Effective in 2025, the Company transitioned to an unlimited paid time off policy, which provides
employees with flexibility to manage their personal and professional needs without a fixed
accrual cap. The Company offers a 401(k) retirement plan to all eligible employees. The employer
matching contribution was suspended in 2024 and discontinued in 2025. The Company intends
to reassess the matching contribution as its financial position improves.

Recent
Developments

Emerging Markets

In March 2026, we announced that emerging U.S. market average deposit balances increased 29% over the twelve months
ended February 4, 2026, driving total average deposit balances up 4.5%, and that emerging U.S. markets represented 31% of the Company’s
average deposit balances at the time of the announcement.

420
IT Solutions Acquisition

On
December 19, 2025, Safe Harbor Managed Services LLC, a wholly-owned subsidiary of the Company, completed the acquisition of substantially
all of the assets of 420 IT Solutions. 420 IT Solutions is engaged in the business of providing third-party professional advisory and
technology services to the cannabis industry. The aggregate purchase price for the acquired assets consisted of 125,000 Earnout Shares
(as defined below), plus the assumption of certain identified liabilities under contracts assigned to the Company. The acquisition included
the transfer of customer contracts, the registered trademark “420 IT Solutions”, domain name registrations, and other intellectual property. No cash consideration was paid at closing. In connection
with the acquisition, 420 IT Solutions’ founders, joined the Company to lead the third-party
professional advisory and technology services division. See Part II, Item 7., “Management’s Discussion and Analysis of Financial
Condition and Results of Operations for the Years ended December 31, 2025 and 2024––Acquisition of 420 IT Solutions.”

Second
Amended CAA

During the fourth quarter of 2025, SHF LLC, a wholly-owned subsidiary of the Company, and PCCU reached agreement
on the material economic terms of the Second Amended CAA on or about October 1, 2025, following completion of the September 2025 Recapitalization.
The written agreement was formally executed on February 4, 2026; the intervening period involved only procedural and documentation matters
that did not affect the substance of the agreed terms. Accordingly, the Company has given effect to the Second Amended CAA from October
1, 2025, consistent with ASC 606 contract modification guidance. Under the Second Amended CAA, we receive up to 65% of loan program income
generated by PCCU’s CRB loan portfolio, an increase from the approximately 35% share in effect under the First Amended CAA. In exchange,
we are obligated to indemnify PCCU for up to 65% of net losses on any loan default covered by the Second Amended CAA. See Part II, Item
7. “Management’s Discussion and Analysis of Financial Condition and Results of Operations for the years ended December 31, 2025 and
December 31, 2024––Relationship with PCCU” and “Management’s Discussion and Analysis of Financial Condition and
Results of Operations for the years ended December 31, 2025 and December 31, 2024––Related Party Relationship with PCCU.”

20

September
2025 Recapitalization

On
August 27, 2025, the Company issued Convertible Promissory Notes (the “Notes”) to certain accredited investors with an
aggregate principal amount of $0.6 million, a 20% original issue discount (“OID”) and maturity date of September 9, 2026.
The conversion price of the Notes is the lesser of (i) a twenty percent (20%) discount to the average volume-weighted average price
(“VWAP”) of the Common Stock for the twenty (20) consecutive trading days ending on the trading day immediately prior to
the execution date of the Note and (ii) a twenty percent (20%) discount to the average VWAP of the Common Stock for the twenty (20)
consecutive trading days ending on the trading day immediately preceding the date of a conversion notice, subject to adjustment as
provided in the Note. On September 9, 2025, the Company issued an additional Note to an accredited investor in the principal amount
of $0.1 million on identical terms, bringing the aggregate principal amount to $0.7 million.

On September 17, 2025, we established the ELOC
with CREO, which provided we may sell to CREO up to $150 million of Common Stock and granted us and CREO the mutual right to
agree to increase this amount to $500 million.

On September 30, 2025, all outstanding Notes were exchanged for an aggregate of 825
shares of the Series B Preferred Stock and Series B Warrants to purchase 53,127 shares of Common Stock. Also on September 30, 2025,
the Company entered into Exchange and Cancellation Agreements (each, an “Exchange and Cancellation Agreement”) with each
of Midtown East Management NL, LLC (“Midtown”), which was subsequently assigned in part to Verdun Investments LLC
(“Verdun”) and Vellar Opportunity Fund SPV LLC – Series 1 (“Vellar”) relating to a Forward Purchase
Agreement (the “FPA”) that the Company initially entered into on June 16, 2022. In exchange for each counterparty
irrevocably cancelling, waiving, and terminating all of their rights under the FPA, the Company issued an aggregate of 5,002 shares
of Series B Preferred Stock and Series B Warrants to purchase 322,111 shares of Common Stock.

We
refer to these Notes transactions, the entrance into the ELOC and the termination of the FPA collectively as the “September 2025
Recapitalization.” The September 2025 Recapitalization eliminated approximately $18 million in debt and raised over $6.7 million
in new capital and also resulted in the establishment of the $150 million ELOC that can potentially be expanded to $500 million, thereby
meaningfully improving our ability to support our lending commitments and portfolio growth. See Part II, Item 7., “Management’s
Discussion and Analysis of Financial Condition and Results of Operations for the Years ended December 31, 2025 and 2024––Relationship
with PCCU” and Part II, Item 7., “Management’s Discussion and Analysis of Financial Condition and Results of Operations
for the Years ended December 31, 2025 and 2024––Gain on Extinguishment of Debt.”

Corporate
History

The
Company was founded in 2015 to address the lack of reliable and compliant financial services available to CRBs in Colorado. At that time,
many financial institutions were unwilling to serve the industry due to regulatory uncertainty and compliance burdens. Drawing on regulatory
and banking experience, we developed a compliance program designed to assist financial institutions in providing services to CRBs while
addressing BSA and AML obligations.

Our
program provides onboarding, monitoring, and validation services to financial institutions seeking to offer traditional banking products
to licensed cannabis, hemp, and CBD operators, as well as ancillary businesses that provide goods and services to the cannabis industry.
As cannabis legalization has expanded beyond Colorado, our operations have grown to support financial institutions that provide services
in 41 states and territories where cannabis is permitted for medical or adult use.

Our
principal executive offices are located at 1526 Cole Boulevard, Suite 250, Golden, Colorado 80401, and our telephone number is (303)
431-3435. Our website is www.shfinancial.org; information on our website is not incorporated by reference into this Form 10-K.

21

Available
Information

We
maintain a website at the address shfinancial.org. On our website, you can access, free of charge, our Annual Report on Form 10-K, Quarterly
Reports on Form 10-Q, Current Reports on Form 8-K, our annual proxy statement on Schedule 14A, and amendments to those materials filed
or furnished pursuant to Sections 13(a) and 15(d) of the Exchange Act. Materials are available online as soon as reasonably practicable
after we electronically file such material with, or furnish it to, the SEC. In addition, the SEC maintains a website at the address www.sec.gov
that contains the information we file or furnish electronically with the SEC. The information contained on our website or on the SEC’s
website is not incorporated by reference in, or considered part of, this Form 10-K. Our principal executive offices are located at 1526
Cole Boulevard, Suite 250, Golden, Colorado 80401, and our telephone number is (303) 431-3435

Emerging
Growth Company

We
are an emerging growth company (“EGC”) as defined in the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”).
As such, we are eligible to take advantage of certain exemptions from various reporting requirements that are applicable to other public
companies that are not “emerging growth companies,” including, but not limited to, not being required to comply with the
auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002 (“SOX”), reduced disclosure obligations
regarding executive compensation in our periodic reports and proxy statements, and exemptions from the requirements of holding a non-binding
advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.

In
addition, Section 107 of the JOBS Act also provides that an EGC can take advantage of the extended transition period provided in Section
7(a)(2)(B) of the Securities Act, for complying with new or revised accounting standards. In other words, an EGC can delay the adoption
of certain accounting standards until those standards would otherwise apply to private companies. We intend to take advantage of the
benefits of this extended transition period, for as long as it is available. We will remain an EGC until the earlier of (1) the last
day of the fiscal year (a) following the fifth anniversary of the date of the first sale of our common equity securities pursuant to
an effective registration statement under the Securities Act, which is December 31, 2026, and (b) in which we have total annual gross
revenue of at least $1.07 billion, (2) the date on which we are deemed to be a large accelerated filer, which means the market value
of our Common Stock that is held by non-affiliates exceeds $700 million as of the last business day of our most recently completed second
fiscal quarter, and (3) the date on which we have issued more than $1.0 billion in non-convertible debt during the prior three-year period.
References herein to “emerging growth company” have the meaning provided in the JOBS Act. The Company will cease to be an EGC on December 31, 2026.

Smaller
Reporting Company

We
are a “smaller reporting company” as defined in Item 10(f)(1) of Regulation S-K, which allows us to take advantage of certain
exemptions from disclosure requirements including exemption from compliance with the auditor attestation requirements of Section 404.
We will remain a smaller reporting company until the last day of the fiscal year in which (i) the market value of the shares of our Common
Stock held by non-affiliates exceeds $250.0 million as of the prior June 30, and (ii) our annual revenue exceeded $100.0 million during
such completed fiscal year or the market value of the shares of our Common Stock held by non-affiliates exceeds $700.0 million as of
the prior June 30. To the extent we take advantage of such reduced disclosure obligations, it may also make comparison of our financial
statements with other public companies difficult or impossible.